The Health Sciences Authority (HSA) of Singapore and the Department of Health (DoH) of Hong Kong Special Administrative Region have signed a Memorandum of Understanding (MOU) to enhance cooperation in healthcare regulatory matters. Signed on 13 August 2025, this agreement aims to strengthen ties between the two authorities by facilitating the exchange of information, best practices, and expertise across a wide range of health products, including pharmaceuticals, medical devices, and traditional medicines.
The MOU outlines plans for technical cooperation and mutual exchange of regulatory information, particularly concerning tobacco products and vaping devices. It also supports the exchange of regulatory experts, participation in scientific conferences, and collaboration in training courses and joint projects. This partnership underscores the shared commitment of Singapore and Hong Kong to ensure the safety, quality, and efficacy of health products.
HSA CEO Adjunct Professor Dr Raymond Chua stated, “By combining our expertise and sharing best practices, we can better tackle the emerging challenges in healthcare regulation, harness opportunities, and strengthen public health protection in both jurisdictions.”
The signing ceremony, held at the Ministry of Health’s College of Medicine Building, was attended by Singapore’s Minister for Health, Ong Ye Kung, and Hong Kong’s Secretary of Health, Professor Lo Chungmau. This collaboration marks a significant step forward in regulatory cooperation, aiming to advance regulatory excellence in both regions.
“`
